Honestly, I don't care about the theories regarding the FDA. CytoDyn has trials in place and it seems that the only thing that will propel the share price higher is positive results. I just don't see CytoDyn getting approval from any country until the data is released. I'm not trying to rain on anyone's parade, I'm just being realistic.
Similar news to yesterday's Mexico news will result in the same daily pattern that we've been watching. A bump on the day of the news, then it slowly bleeds out until the next headline.
We need objective data from an unbiased source. Further speculative statements from CytoDyn is not likely to increase share price in any significant way. I'm not saying their statements aren't based on data, but it just needs to come from an outside source with no ties to CytoDyn. Positive data from the trials will serve this purpose as well as the peer reviewed article, once it's officially published. Investors want confirmation. And I am rather sure they will receive precisely that...